According to studies, unregulated skin-lightening products contain harmful substances, including mercury, that can pose ...

Harish suffered kidney damage after using a skin-whitening cream that had no labels or ingredients listed. Treated for ...

As skin-lightening creams and even the injectable glutathione are increasingly being used for skincare, there are concerns ...

Analysts at Wedbush lifted their Q4 2024 EPS estimates for shares of argenx in a report released on Monday, January 13th.

A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com, in the "Investors" section under the "News and Events" page. A replay of the conference webcast will ...

Initiate the third Cohort of the Phase 2 Basket study (WAL0921-02) in Rare glomerular kidney diseases, including focal segmental glomerulosclerosis (FSGS), treatment resistant minimal change disease ...

HONG KONG, Jan 9, 2025 - (ACN Newswire) – The trading of TCE (T Cell Engager) bispecific antibodies remains hot, and multinational pharmaceutical companies (MNCs) are still placing orders frantically.

competing successfully with other companies that are seeking to develop treatments for primary membranous nephropathy, immune ...

(NASDAQ:ARGX – Free Report) had its price target lifted by Piper Sandler from $620.00 to $725.00 in a research report report published on Tuesday morning,Benzinga reports. The brokerage currently has ...

Budoprutug is under clinical development by Climb Bio and currently in Phase II for Membranous Glomerulonephritis. According to GlobalData, Phase II drugs for Membranous Glomerulonephritis does not ...